FLT3 and melanoma: The SMGs identified in our mouse models included well-described melanoma and leukemia oncogenes and tumour suppressors (Muc4, Pten, Grin2a, Dnmt3a, Npm1 and Flt3) [14–16] reinforcing the WES validation and the subsequent filtering of SMGs.